Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model.

Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Russo TA, Balthasar J.

J Pharmacol Exp Ther. 2019 Jan 3. pii: jpet.118.253617. doi: 10.1124/jpet.118.253617. [Epub ahead of print]

2.

Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae.

Russo TA, Olson R, Fang CT, Stoesser N, Miller M, MacDonald U, Hutson A, Barker JH, La Hoz RM, Johnson JR.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00776-18. doi: 10.1128/JCM.00776-18. Print 2018 Sep.

PMID:
29925642
3.

The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.

Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA.

Infect Immun. 2017 Nov 17;85(12). pii: e00591-17. doi: 10.1128/IAI.00591-17. Print 2017 Dec.

4.

Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge.

Bulger J, MacDonald U, Olson R, Beanan J, Russo TA.

Infect Immun. 2017 Sep 20;85(10). pii: e00093-17. doi: 10.1128/IAI.00093-17. Print 2017 Oct.

5.

The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.

Russo TA, Manohar A, Beanan JM, Olson R, MacDonald U, Graham J, Umland TC.

mSphere. 2016 May 11;1(3). pii: e00082-16. doi: 10.1128/mSphere.00082-16. eCollection 2016 May-Jun.

6.

Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.

Sutton KA, Breen J, MacDonald U, Beanan JM, Olson R, Russo TA, Schultz LW, Umland TC.

Acta Crystallogr D Biol Crystallogr. 2015 Aug;71(Pt 8):1736-44. doi: 10.1107/S139900471501189X. Epub 2015 Jul 31.

PMID:
26249354
7.

Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.

Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA.

Infect Immun. 2015 Aug;83(8):3325-33. doi: 10.1128/IAI.00430-15. Epub 2015 Jun 8.

8.

Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae.

Russo TA, Olson R, Macdonald U, Metzger D, Maltese LM, Drake EJ, Gulick AM.

Infect Immun. 2014 Jun;82(6):2356-67. doi: 10.1128/IAI.01667-13. Epub 2014 Mar 24.

9.

The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA.

Infect Immun. 2013 Mar;81(3):915-22. doi: 10.1128/IAI.01184-12. Epub 2013 Jan 7.

10.

In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.

Umland TC, Schultz LW, MacDonald U, Beanan JM, Olson R, Russo TA.

MBio. 2012 Aug 31;3(4). pii: e00113-12. doi: 10.1128/mBio.00113-12. Print 2012.

11.

Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.

Kong Q, Beanan JM, Olson R, Macdonald U, Shon AS, Metzger DJ, Pomakov AO, Russo TA.

Virulence. 2012 May 1;3(3):309-18. doi: 10.4161/viru.20383. Epub 2012 May 1.

12.

Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.

Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP.

PLoS One. 2011;6(10):e26734. doi: 10.1371/journal.pone.0026734. Epub 2011 Oct 24.

13.

Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):981-9. doi: 10.1007/s10096-011-1396-6. Epub 2011 Sep 15.

PMID:
21918907
14.

The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA.

Infect Immun. 2010 Sep;78(9):3993-4000. doi: 10.1128/IAI.00366-10. Epub 2010 Jul 19.

15.

Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.

Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC.

J Infect Dis. 2009 Feb 15;199(4):513-21. doi: 10.1086/596317.

PMID:
19143563
16.

Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.

Russo TA, Beanan JM, Olson R, MacDonald U, Cope JJ.

Vaccine. 2009 Jan 14;27(3):388-95. doi: 10.1016/j.vaccine.2008.10.082. Epub 2008 Nov 17.

PMID:
19014988
17.

Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA.

Infect Immun. 2008 Aug;76(8):3577-86. doi: 10.1128/IAI.00269-08. Epub 2008 Jun 9.

18.

A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR.

Vaccine. 2007 May 10;25(19):3859-70. Epub 2007 Feb 5.

19.

E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.

Russo TA, Davidson BA, Genagon SA, Warholic NM, Macdonald U, Pawlicki PD, Beanan JM, Olson R, Holm BA, Knight PR 3rd.

Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L207-16. Epub 2005 Apr 1.

Supplemental Content

Loading ...
Support Center